1st Juni 2021
FILTERN NACH
TERMINE
- Juni 2021
- Mai 2021
- April 2021
- März 2021
- Februar 2021
- Januar 2021
- Dezember 2020
- September 2020
- Juni 2020
- April 2020
- März 2020
- Januar 2020
- Dezember 2019
- November 2019
- September 2019
- Februar 2019
- Januar 2019
- September 2018
- August 2018
- Mai 2018
- April 2018
- März 2018
- Februar 2018
- Januar 2018
- Dezember 2017
- September 2017
- Juni 2017
- April 2017
- Januar 2017
- August 2016
Neuigkeiten
Bleiben Sie auf dem neuesten Stand. Hier finden Sie unsere Pressemitteilungen. Hier können Sie sich über bevorstehende Veranstaltungen informieren, an denen Curium teilnehmen wird.
5th Mai 2021
RadioMedix & Curium Announce Detectnet™ (copper Cu 64 dotatate injection) Inclusion on NCCN Guidelines®
4th Mai 2021
Curium Announces Filing of a Generic Version of DaTscan™ (Ioflupane I 123 Injection) in the U.S.
28th April 2021
Curium to Expand Noblesville Facility’s Workforce
23rd März 2021
RadioMedix & Curium Announce Simplified Coding for Detectnet™ (copper Cu 64 dotatate injection)
17th März 2021
A statement on the use of Xenon Xe 133 Gas during the COVID-19 pandemic
2nd März 2021
Eckert & Ziegler’s GalliaPharm® distributed by Curium in France
2nd Februar 2021
Curium is attending these global congresses in 2021
26th Januar 2021
RadioMedix & Curium Announce Permanent HCPCS Code for Detectnet™ (copper Cu 64 dotatate injection)
9th Dezember 2020
RadioMedix & Curium Announce CMS Transitional Pass-Through Status for Detectnet™ (copper Cu 64 dotatate injection)
8th September 2020
RadioMedix and Curium Announce FDA Approval of Detectnet (copper Cu 64 dotatate injection) in the U.S.
9th Juni 2020
Curium Announces Drug Master File and Active Substance Master File for Germanium-68 in the U.S. and Europe
16th April 2020
Eine Erklärung von Curium zu COVID-19 und unseren Maßnahmen
24th März 2020
Curium Announces Approval of PulmotechTM MAA (kit for the preparation of technetium Tc 99m albumin aggregated injection) by the U.S. Food and Drug Administration
12th März 2020
RadioMedix and Curium Announce copper Cu 64 dotatate injection Was Granted Priority Review by the U.S. FDA
3rd März 2020
Curium Acquires Zevacor Molecular Strengthening Its PET Portfolio
30th Januar 2020
Curium is attending these global congresses in 2020
7th Januar 2020
RadioMedix and Curium Announce FDA Filing of copper Cu 64 dotatate injection New Drug Application
2nd Dezember 2019
Curium Acquires Finnish Radiopharmaceuticals Company MAP Medical Technologies Oy
16th November 2019